Drug · DIN 02424231
MINT-PREGABALIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since May 2, 2014.
- Drug Identification Number (DIN)
- 02424231
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pregabalin N02BF02
- Class
- Human
- Record last updated
- September 2, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PREGABALIN | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 23, 2021: NOC 26714Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
- May 2, 2014: NOC 15567Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named MINT-PREGABALIN
- DIN 02423804 · Marketed
- DIN 02423812 · Marketed
- DIN 02424185 · Marketed
- DIN 02424207 · Marketed
- DIN 02424193 · Approved
- DIN 02424215 · Approved
- DIN 02424223 · Approved